331 research outputs found
Obciążenie chorobami układu sercowo-naczyniowego u osób hospitalizowanych w szpitalu w Guangzhou w Chinach, w latach 2006–2015
Introduction. To explore the epidemiological characters of cardiovascular disease (CVD) in patients and to give a certain clues for disease prevention and clinical treatment.
Material and methods. We carried out an investigation using retrospective study method by the medical records retrieval system, and extracted the data of inpatients suffered from CVD in a hospital in Guangzhou from 2006 to 2015, including age, gender, disease onset time, clinical diagnosis, hospitalization days, cost and so on.
Results. The average admissions per 5 years kept increasing in the study period. Most inpatients suffered from the CVD in December (n = 9288, 9.10%), while least in February (n = 7309, 7.16%). Most of the inpatients were 66–75-years- -old (n = 24,891, 24.37%). Gender ratio (male vs. female) of CVD inpatients showed a downward trend came with age. The gender ratio was 1.9 and 0.99 among inpatients below 26-years-old and above 85-years-old, respectively. Most common CVD were ischemic heart diseases (29.46%), cerebrovascular diseases (21.59%) and hypertensive diseases (15.18%). The adjusted hospitalization cost was 4600.30 USD in 2006 and 5473.66 USD in 2006, while the average hospitalization days were 15.63 in 2006 and 9.98 in 2015.
Conclusions. More attention should be paid to the middle and elderly people with CVD risk factors, especially the senile women, to reduce the disease burden. The change of gender ratio suggested there may be other significant causes leading to the gender differences besides estrogen.Wstęp. Badanie przeprowadzono w celu oceny cech epidemiologicznych chorych hospitalizowanych z powodu chorób układu sercowo-naczyniowego i sformułowanie wskazówek dotyczących zapobiegania tym chorobom oraz ich leczenia.
Materiał i metody. Badanie przeprowadzono w sposób retrospektywny na podstawie analizy danych medycznych, korzystając z dokumentacji pacjentów hospitalizowanych z powodu chorób układu sercowo-naczyniowego w szpitalu w Guangzhou w latach 2006–2015. Dane włączone do analizy obejmowały między innymi wiek, płeć, czas rozpoczęcia choroby, rozpoznanie kliniczne, okres hospitalizacji (dni), koszty związane z hospitalizacją.
Wyniki. Średnia liczba hospitalizacji na 5 lat zwiększała się stale w badanym okresie. Najwięcej chorych zgłaszało się do szpitala z powodu chorób układu sercowo-naczyniowego w grudniu (n = 9288; 9,10%), natomiast najmniej w lutym (n = 7309; 7,16%). Największą grupę hospitalizowanych stanowiły osoby w wieku 66–75 lat (n = 24 891; 24,37%). Wartość współczynnika płci chorych (stosunek liczby mężczyzn do liczby kobiet) wśród osób hospitalizowanych z powodu chorób układu sercowo-naczyniowego zmniejszała się z wiekiem. Współczynnik ten wynosił 1,9 i 0,99, odpowiednio, w grupach chorych w wieku poniżej 26 lat oraz powyżej 85 lat. Do najczęstszych CVD należały choroba niedokrwienna serca (29,46%), choroba naczyniowa mózgu (21,59%) i nadciśnienie tętnicze (15,18%). Skorygowane koszty hospitalizacji wynosiły 4600,30 USD w 2006 roku i 5473,66 USD w 2015 roku, natomiast średni czas hospitalizacji wynosił odpowiednio 15,63 i 9,98 dnia.
Wnioski. Aby zmniejszyć obciążenie chorobami sercowo-naczyniowymi należy zwrócić większa uwagę na osoby w średnim i podeszłym wieku, u których występują czynniki ryzyka sercowo-naczyniowego; dotyczy to zwłaszcza starszych kobiet. Zmiana proporcji płci chorych sugeruje, że oprócz estrogenu mogą istnieć inne przyczyny powodujące różnicę w liczbie zachorowań na choroby sercowo-naczyniowe
Evaluation of top-down mass spectral identification with homologous protein sequences
BACKGROUND:
Top-down mass spectrometry has unique advantages in identifying proteoforms with multiple post-translational modifications and/or unknown alterations. Most software tools in this area search top-down mass spectra against a protein sequence database for proteoform identification. When the species studied in a mass spectrometry experiment lacks its proteome sequence database, a homologous protein sequence database can be used for proteoform identification. The accuracy of homologous protein sequences affects the sensitivity of proteoform identification and the accuracy of mass shift localization.
RESULTS:
We tested TopPIC, a commonly used software tool for top-down mass spectral identification, on a top-down mass spectrometry data set of Escherichia coli K12 MG1655, and evaluated its performance using an Escherichia coli K12 MG1655 proteome database and a homologous protein database. The number of identified spectra with the homologous database was about half of that with the Escherichia coli K12 MG1655 database. We also tested TopPIC on a top-down mass spectrometry data set of human MCF-7 cells and obtained similar results.
CONCLUSIONS:
Experimental results demonstrated that TopPIC is capable of identifying many proteoform spectrum matches and localizing unknown alterations using homologous protein sequences containing no more than 2 mutations
In vitro evaluation of anticancer nanomedicines based on doxorubicin and amphiphilic Y-shaped copolymers
Four monomethoxy poly(ethylene glycol)-poly(L-lactide-co-glycolide)2 (mPEG-P( LA-co-GA)2) copolymers were synthesized by ring-opening polymerization of L-lactide and glycolide with double hydroxyl functionalized mPEG (mPEG-(OH)2) as macroinitiator and stannous octoate as catalyst. The copolymers self-assembled into nanoscale micellar/vesicular aggregations in phosphate buffer at pH 7.4. Doxorubicin (DOX), an anthracycline anticancer drug, was loaded into the micellar/vesicular nanoparticles, yielding micellar/vesicular nanomedicines. The in vitro release behaviors could be adjusted by content of hydrophobic polyester and pH of the release medium. In vitro cell experiments showed that the intracellular DOX release could be adjusted by content of P(LA-co-GA), and the nanomedicines displayed effective proliferation inhibition against Henrietta Lacks’s cells with different culture times. Hemolysis tests indicated that the copolymers were hemocompatible, and the presence of copolymers could reduce the hemolysis ratio of DOX significantly. These results suggested that the novel anticancer nanomedicines based on DOX and amphiphilic Y-shaped copolymers were attractive candidates as tumor tissular and intracellular targeting drug delivery systems in vivo, with enhanced stability during circulation and accelerated drug release at the target sites
Excisanin A suppresses proliferation by inhibiting hypoxiainducible factor-1α expression in human hepatocellular carcinoma cells
Purpose: To investigate the effect of excisanin A on human hepatocellular carcinoma cells as well as to elucidate its mechanism of action.
Methods: Molecular docking was used to determine the binding characteristics of excisanin A to HIF-1α protein. The transcriptional activation and viability of excisanin A were assessed using Luciferase reporter and MTT assay. The HIF-1α protein in the nucleus was assayed using western blot and immunofluorescence. HIF-1α and VEGF mRNA levels were evaluated using reverse-transcription polymerase chain reaction (RT-PCR). Cell proliferation was determined by flow cytometry, as well as by EdU and clonogenic assays. In vivo tumor growth was assessed in a murine xenograft model of SKHep1 cells.
Results: Excisanin A inhibited HIF-1α transcriptional activation, as well as HIF-1α protein synthesis (p < 0.001). Excisanin A also reduced VEGF protein and mRNA expressions (p < 0.001). In addition, the compound inhibited the proliferation of hepatocellular carcinoma cells. and tumor growth in the xenograft tumor model.
Conclusion: Excisanin A is a potent HIF-1α inhibitor, supporting its potential development for human hepatoma therapy.
Keywords: Excisanin A, HIF-1α, Protein synthesis, Hepatoma therap
Case report: Successful treatment of non-bullous lichen planus pemphigoides with dupilumab
Lichen planus pemphigoides (LPP) is a rare autoimmune bullous disease, characterized by the coexistence of lichen planus and subepidermal bullae. However, the minority of LPP patients present with papules rather than vesicles or blisters, which is defined as non-bullous LPP. The diagnosis of LPP relies on manifestations, histopathology, serological assay, and direct immunofluorescence of linear disposition of IgG and/or C3 at the basement membrane zone. Up to now, no standard therapeutic strategies have been proposed for the treatment of LPP. Herein, we describe an uncommon non-bullous LPP patient with widespread papules and erythema, probably induced by vaccination. During hospitalization, he had a poor response to the conventional treatment of topical and systemic corticosteroids, and his condition was finally alleviated by the addition of dupilumab. For LPP patients with a traditional medication failure, or who were not suitable for a higher dose of corticosteroids, a combination with dupilumab could be an alternative option
The Basic Differential Equations of Self-Anchored Cable-Stayed Suspension Bridge
The static behavior of self-anchored cable-stayed suspension bridge under vertical load is described with the continuum method. Based on the partition generalized variation principle, considering the compression-bending coupling effect of the main girder and the tower, the large displacement incomplete generalized potential energy functional of three-span self-anchored cable-stayed suspension bridge is established. Then, the basic differential equations of self-anchored cable-stayed suspension bridge are derived through constraint variation. Taking a self-anchored cable-stayed suspension bridge with main span 100 m, for example, the results by the proposed analytic method agree with that of numerical analysis. Therefore, the basic differential equations proposed in this paper could be applied to the preliminary analysis of self-anchored cable-stayed suspension bridge. The equations also provide a theoretical basis to describe the static behavior of this type of bridge
- …